Schedule of oral presentations

IDTitleSessionPresenting author 
01.1The future of review production for CochraneSession 1Jessica Thomas 

1 to 5

Day 1 
Tue 23 Sep 11.00-12.30

01.2Personally tailored, multilingual, up-to-date  evidence-based summaries of effects of care, when and where you want it: an EU bidSession 1Marianna Purgato 
01.3Piloting living systematic reviews in traumatic brain injurySession 1Anneliese Synnot 
01.4linkedPICO project: how to make different tools and platforms in the medical knowledge ecosystem talk past their silosSession 1Linn Brandt 
02.1Enhancing the acceptance and implementation of summary of findings tables in Cochrane Reviews: user testing studySession 2Alonso Carrasco-Labra 
02.2Enhancing the acceptance and implementation of summary of findings tables in Cochrane Reviews: two non-inferiority randomized controlled trialsSession 2Alonso Carrasco-Labra 
02.3An approach to evaluate the quality of evidence from a network meta-analysisSession 2Cinzia Del Giovane 
02.4Rating the quality of the evidence for the studies that evaluate the importance of the outcomes of interestSession 2Pablo Alonso 
03.1Impact of missing outcome data for participants in trials included in five Cochrane Reviews: an imputation study Session 3Lara Kahale 
03.2Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological studySession 3Robin Christensen 
03.3The moral dimensions of meta-analysis: a grounded theory of the meta-analytic processSession 3Ian Shrier 
03.4Prediction study risk of bias assessment tool (PROBAST)Session 3Robert Wolff 
04.1Global burden of skin disease in 2010 and systematic reviews and protocols in Cochrane Database of Systematic ReviewsSession 4Robert Dellavalle 
04.2Systematic reviews addressing identified policy priorities in Eastern Mediterranean countries: a situational analysis Session 4Elie Akl  
04.3Setting research priorities with multiple professions and service usersSession 4Sandy Oliver 
04.4Update of the Cochrane Review of interventions for preventing obesity in children: priority settingSession 4Elizabeth Waters 
05.1Introducing LATITUDES: a library of assessment tools and instruments used to assess data validity in evidence synthesesSession 5Penny Whiting 
05.2Methodological considerations for assessing risk of bias in non-randomized studiesSession 5Jonathan Sterne 
05.3A new tool to assess risk of bias in non-randomized studiesSession 5Jonathan Sterne 
05.4ROBIS: a new tool to assess the risk of bias in a systematic reviewSession 5Penny Whiting 
Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews

Session 6

Zbys Fedorowicz 

6 to 10

Day 2 
Wed 24 Sep 11.00-12.30

06.2Using text mining technologies can reduce screening workload in systematic reviews in practice as well as in theorySession 6James Thomas 
06.3Automatic information retrieval: citation tracking, deduplication and full-text fetchingSession 6Guy Tsafnat 
06.4Anywhere Cochrane Reviews: responsive web design, the 'connected article' and Cochrane evidenceSession 6Gavin Stewart 
07.1Do we have Cochrane Reviews for the more relevant questions? Are they the best choice? Analysis of clinical questions in internal medicineSession 7Gabriel Rada 
07.2Evaluating the impact of Cochrane ReviewsSession 7Daksha Trivedi 
07.3Cochrane Reviews: the linchpins of knowledge translation and impact Session 7Philippa Middleton 
07.4‘Buying’ into Cochrane: how do Fields measure success?Session 7Craig Lockwood 
08.1Policy 'buddies': policymaker and researcher engagement for evidence-informed policy Session 8Taryn Young 
08.2Seizing opportunities: engaging policy makers in evidence informed discussions, planning and policy makingSession 8Krishna Aryal 
08.3Linking diagnostic test accuracy reviews to global priorities: case study of TBSession 8Marty Richardson 
08.4Social values underlying priority settingSession 8David Gough 
09.1Completeness of outcomes description reported in low-back pain rehabilitation interventions: a survey of trials included in Cochrane Reviews Session 9Silvia Gianola 
09.2Survey of outcomes in Cochrane Reviews: support for ‘core outcome set’ (COS) developmentSession 9Valerie Smith 
09.3Progressing towards core outcomes in gestational diabetes clinical trials and Cochrane ReviewsSession 9Emily Bain 
09.4Do Cochrane Reviews measure enough of what patients want? A collaborative study of Cochrane Reviews on HIV/AIDSSession 9Ian Saldanha 
10.1Exploring treatment by covariate interactions in Cochrane Reviews: recent practiceSession 10Sarah Donegan 
10.2Reliability of estimating odds ratios of response and the corresponding standard errors from continuous rating scale scores for meta-analysis: a case study in trials on depression treatmentSession 10Ramona Meister 
10.3Multiple imputation of systematically missing predictors in an individual participant data meta-analysis: a generalized approach using MICESession 10Thomas Debray 
10.4Testing for intervention effects in the random-effects model: a comparison of different statistical methodsSession 10Joseph Beyene 
11.1Facilitating research on research using SWAR (studies within a review) and SWAT (studies within a trial)Session 11Mike Clarke 

11 to 16

Day 3 
Thu 25 Sep 11.00-12.30

11.2The EMBASE project: an analysis of highlighted words and phrasesSession 11Anna Noel-Storr 
11.3Citation screening in systematic reviews: two approaches, two authors and time taken (SWAR-1 (Study Within A Review 1))Session 11Mike Clarke 
12.1From summary to synthesis: a review of statistical synthesis and presentation methods used in complex reviewsSession 12Joanne McKenzie 
12.2Can Qualitative Comparative Analysis help us to identify important components of complex interventions?Session 12James Thomas 
12.3Characteristics of realist synthesis reviews: a systematic mapping review of realist reviews Session 12Rigmor Berg 
12.4Assessing how much confidence to place in findings from qualitative evidence syntheses: a new version of the CERQual toolSession 12Jane Noyes 
13.1Do Cochrane summaries help student midwives understand the findings of Cochrane reviews: the BRIEF randomised trialSession 13Fiona Alderdice 
13.2SWAR 2: How much do you need? Can readers get the key messages from summaries of Cochrane Reviews, without reading the full review?Session 13Lisa Maguire 
13.3Online filter bubbles and confirmation bias in health care: narrative of a vaccine skepticSession 13Giordano Pérez Gaxiola 
13.4Implementing multilayered presentation formats in a new generation of trustworthy clinical practice guidelinesSession 13Linn Brandt 
14.1A systematic review on the impact of studies that are not fully published on results of meta-analysesSession 14Joerg Meerpohl 
14.2An empirical investigation of the potential impact of selective inclusion of results in systematic reviews of interventionsSession 14Matthew Page 
14.3Massive production of meta-analyses of antidepressants with industry authorship or industry-related conflictsSession 14Shanil Ebrahim 
14.4Publication bias tests for survival data: a simulation studySession 14Thomas Debray 
15.1Relationship between global burden of disease and quantity of published randomized controlled trialsSession 15Connor Emdin 
15.2The use of systematic reviews in the design of randomized controlled trials of acupuncture: a systematic reviewSession 15Kun Hyung Kim 
15.3Quality of descriptions of rehabilitation interventions in low back pain: a review of published randomized controlled trialsSession 15Silvia Gianola 
15.4Reporting of randomized clinical trials discontinued due to poor recruitment: a literature review Session 15Erik VonElm 
16.1A new approach to update Cochrane Reviews focusing on the 'Summary of findings' (SoFs)Session 16Karla Soares-Weiser 
16.2Updating for quality: reflections on our editorial policySession 16Paul Garner 
16.3Five evidence ‘game changers’ in 2013 and what this means for Cochrane ReviewsSession 16Brian Alper 
17.1The importance of process evaluation: a tale of two reviewsSession 17Elizabeth Kristjansson 

17 to 22

Day 4 
Fri 26 Sep 11.00-12.30

17.2Intervention Component Analysis (ICA): enhancing the “implementability” of review findings on complex interventionsSession 17Katy Sutcliffe 
17.3Using evidence syntheses: views and experiences of public health decision makers and review authors in the United KingdomSession 17Daniel Francis 
17.4The Cochrane Review moving beyond RCTs: philosophical notions of causality and its implicationsSession 17Jackie Chandler 
18.1The quality of evidence is a key determinant of strength of recommendationsSession 18Benjamin Djulbegovic 
18.2Use of information from summary of findings tables in the clinical practice guidelines development: a pilot study in ColombiaSession 18María Ximena Rojas 
18.3Exploring why WHO guideline panels are frequently making strong recommendations based on low study quality (high uncertainty)Session 18Gordon Guyatt 
18.4Understanding the determinants WHO guideline panels consider in making strong recommendations in the face of low or very low confidence (study quality) in effect estimates Session 18Gordon Guyatt 
19.1Multiple systematic reviews published on the same topic area: an analysis of systematic reviews that overlap in contentSession 19Michelle Foisy 
19.2Conducting overviews of reviews: lessons learned since 2006Session 19Michelle Foisy 
19.3Risk of bias: are judgements consistent between reviews?Session 19Sarah Lensen 
19.4Data sharing: is it getting easier to access individual participant data? Experiences from the Cochrane Epilepsy GroupSession 19Sarah Nolan 
20.1Strengthening capacity for producing systematic reviews in low and middle income countriesSession 20Sandy Oliver 
20.2Primer in systematic reviews and research synthesis: helping people to find, appraise, interpret and use systematic reviews in AfricaSession 20Taryn Young 
20.3GAME-IT: explore peoples choices and facilitate teaching by turning evidence processing into a gameSession 20Linn Brandt 
20.4Engaging with younger generations through Students 4 Best Evidence: the follow-upSession 20Holly Millward 
21.1Registration of randomized controlled trials published in PubMed indexed journals: a cross-sectional analysisSession 21Ayodele Odutayo 
21.3Editorial policies and trial registration status for published trials in Indian medical journalsSession 21Soumyadeep Bhaumik 
21.3Changing patterns of clinical trial activity in Australia: 2005-2013Session 21Lisa Askie 
21.4Transparent reporting of a multi-variable prediction model for individual prognosis or diagnosis: the TRIPOD statementSession 21Karel Moons 
22.1Trial data available in FDA and EMA reports: a cross-sectional studySession 22Jeppe Schroll 
22.2How can we accurately diagnose schizophrenia? Challenges in performing Cochrane diagnostic test accuracy reviews in schizophreniaSession 22Karla Soares-Weiser 
22.4Open access and Cochrane ReviewsSession 22Harriet MacLehose